company background image
OSH

Oak Street HealthNYSE:OSH Stock Report

Last Price

US$20.14

Market Cap

US$4.9b

7D

-24.0%

1Y

-62.5%

Updated

19 Jan, 2022

Data

Company Financials +
OSH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

OSH Stock Overview

Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States.

Oak Street Health Competitors

agilon health

NYSE:AGL

US$7.0b

Privia Health Group

NasdaqGS:PRVA

US$2.3b

1Life Healthcare

NasdaqGS:ONEM

US$2.1b

P3 Health Partners

NasdaqCM:PIII

US$1.3b

Price History & Performance

Summary of all time highs, changes and price drops for Oak Street Health
Historical stock prices
Current Share PriceUS$20.14
52 Week HighUS$66.31
52 Week LowUS$19.72
Beta0
1 Month Change-40.71%
3 Month Change-54.65%
1 Year Change-62.51%
3 Year Changen/a
5 Year Changen/a
Change since IPO-49.65%

Recent News & Updates

Dec 22

Oak Street Health Grows Revenue But Struggles With Higher Medical Costs

Oak Street Health went public in August 2020, raising $328 million in an IPO. The firm provides senior populations with primary care services in the Midwest U.S. OSH has been growing revenue but dealing with much higher disease burden costs, which management says it can better control in 2022. I'm Neutral on the stock until we see evidence of management's contention of better results in 2022.

Shareholder Returns

OSHUS HealthcareUS Market
7D-24.0%-3.1%-3.5%
1Y-62.5%13.9%10.2%

Return vs Industry: OSH underperformed the US Healthcare industry which returned 13.9% over the past year.

Return vs Market: OSH underperformed the US Market which returned 10.2% over the past year.

Price Volatility

Is OSH's price volatile compared to industry and market?
OSH volatility
OSH Average Weekly Movement11.3%
Healthcare Industry Average Movement8.0%
Market Average Movement6.6%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market2.4%

Stable Share Price: OSH is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: OSH's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20124,000Mike Pykoszhttps://www.oakstreethealth.com

Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

Oak Street Health Fundamentals Summary

How do Oak Street Health's earnings and revenue compare to its market cap?
OSH fundamental statistics
Market CapUS$4.85b
Earnings (TTM)-US$358.02m
Revenue (TTM)US$1.29b

3.8x

P/S Ratio

-13.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OSH income statement (TTM)
RevenueUS$1.29b
Cost of RevenueUS$1.22b
Gross ProfitUS$63.47m
ExpensesUS$421.50m
Earnings-US$358.02m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-1.49
Gross Margin4.93%
Net Profit Margin-27.81%
Debt/Equity Ratio588.0%

How did OSH perform over the long term?

See historical performance and comparison

Valuation

Is Oak Street Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: OSH ($20.14) is trading below our estimate of fair value ($104.3)

Significantly Below Fair Value: OSH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: OSH is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: OSH is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate OSH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: OSH is overvalued based on its PB Ratio (32.1x) compared to the US Healthcare industry average (2.6x).


Future Growth

How is Oak Street Health forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?

36.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OSH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OSH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OSH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OSH's revenue (28.4% per year) is forecast to grow faster than the US market (9.2% per year).

High Growth Revenue: OSH's revenue (28.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OSH's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Oak Street Health performed over the past 5 years?

-33.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: OSH is currently unprofitable.

Growing Profit Margin: OSH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: OSH is unprofitable, and losses have increased over the past 5 years at a rate of 33.5% per year.

Accelerating Growth: Unable to compare OSH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.5%).


Return on Equity

High ROE: OSH has a negative Return on Equity (-238.46%), as it is currently unprofitable.


Financial Health

How is Oak Street Health's financial position?


Financial Position Analysis

Short Term Liabilities: OSH's short term assets ($1.5B) exceed its short term liabilities ($544.9M).

Long Term Liabilities: OSH's short term assets ($1.5B) exceed its long term liabilities ($1.1B).


Debt to Equity History and Analysis

Debt Level: OSH has more cash than its total debt.

Reducing Debt: Insufficient data to determine if OSH's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OSH has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if OSH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Oak Street Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate OSH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OSH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if OSH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OSH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OSH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.0yrs

Average management tenure


CEO

Mike Pykosz (38 yo)

10yrs

Tenure

US$73,548,691

Compensation

Mr. Michael T. Pykosz, also known as Mike, Co-Founded Oak Street Health, Inc. in 2012 and has been its Chairman & CEO since 2012. He serves as President of Oak Street Health, Inc. He co-founded Oak Street...


CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD73.55M) is above average for companies of similar size in the US market ($USD6.41M).

Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: OSH's management team is considered experienced (4 years average tenure).


Board Members

Experienced Board: OSH's board of directors are considered experienced (6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Oak Street Health, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Oak Street Health, Inc.
  • Ticker: OSH
  • Exchange: NYSE
  • Founded: 2012
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: US$4.852b
  • Shares outstanding: 240.93m
  • Website: https://www.oakstreethealth.com

Number of Employees


Location

  • Oak Street Health, Inc.
  • 30 West Monroe Street
  • Suite 1200
  • Chicago
  • Illinois
  • 60603
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/19 00:09
End of Day Share Price2022/01/18 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.